Advertisement
LAZ vs NMR
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LAZ is a StrongBuy and NMR is a Buy.
Momentum Indicator for LAZ turns positive, indicating new upward trend
LAZ saw its Momentum Indicator move above the 0 level on October 16, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 87 similar instances where the indicator turned positive. In 64 of the 87 cases, the stock moved higher in the following days. The odds of a move higher are at 74%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where LAZ's RSI Oscillator exited the oversold zone, 18 of 26 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 69%.
LAZ moved above its 50-day moving average on November 02, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for LAZ crossed bullishly above the 50-day moving average on November 04, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 69%.
Following a +7.15% 3-day Advance, the price is estimated to grow further. Considering data from situations where LAZ advanced for three days, in 208 of 292 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 39 of 52 cases where LAZ's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 75%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where LAZ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.
LAZ broke above its upper Bollinger Band on November 10, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for LAZ entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 36 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating steady price growth. LAZ’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 63 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.083) is normal, around the industry mean (3.120). P/E Ratio (17.335) is within average values for comparable stocks, (6.734). Projected Growth (PEG Ratio) (1.000) is also within normal values, averaging (0.809). Dividend Yield (0.052) settles around the average of (8.976) among similar stocks. P/S Ratio (1.200) is also within normal values, averaging (16.899).
The Tickeron Profit vs. Risk Rating rating for this company is 92 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LAZ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
NMR's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for NMR turned positive on October 29, 2026. Looking at past instances where NMR's MACD turned positive, the stock continued to rise in 35 of 48 cases over the following month. The odds of a continued upward trend are 73%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where NMR's RSI Indicator exited the oversold zone, 18 of 26 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 69%.
The Momentum Indicator moved above the 0 level on October 29, 2026. You may want to consider a long position or call options on NMR as a result. In 57 of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 70%.
Following a +3.95% 3-day Advance, the price is estimated to grow further. Considering data from situations where NMR advanced for three days, in 206 of 304 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 31 of 56 cases where NMR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 55%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NMR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 55%.
NMR broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for NMR entered a downward trend on November 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 1 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 15 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 46 (best 1 - 100 worst), indicating steady price growth. NMR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 79 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.007) is normal, around the industry mean (3.120). P/E Ratio (0.068) is within average values for comparable stocks, (6.734). Projected Growth (PEG Ratio) (0.815) is also within normal values, averaging (0.809). Dividend Yield (0.041) settles around the average of (8.976) among similar stocks. P/S Ratio (2.472) is also within normal values, averaging (16.899).
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
LAZ | NMR | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 24 | 18 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 85 Overvalued | 79 Overvalued | |
PROFIT vs RISK RATING 1..100 | 92 | 15 | |
SMR RATING 1..100 | 36 | 1 | |
PRICE GROWTH RATING 1..100 | 58 | 46 | |
P/E GROWTH RATING 1..100 | 63 | 97 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
NMR's Valuation (79) in the Investment Banks Or Brokers industry is in the same range as LAZ (85). This means that NMR’s stock grew similarly to LAZ’s over the last 12 months.
NMR's Profit vs Risk Rating (15) in the Investment Banks Or Brokers industry is significantly better than the same rating for LAZ (92). This means that NMR’s stock grew significantly faster than LAZ’s over the last 12 months.
NMR's SMR Rating (1) in the Investment Banks Or Brokers industry is somewhat better than the same rating for LAZ (36). This means that NMR’s stock grew somewhat faster than LAZ’s over the last 12 months.
NMR's Price Growth Rating (46) in the Investment Banks Or Brokers industry is in the same range as LAZ (58). This means that NMR’s stock grew similarly to LAZ’s over the last 12 months.
LAZ's P/E Growth Rating (63) in the Investment Banks Or Brokers industry is somewhat better than the same rating for NMR (97). This means that LAZ’s stock grew somewhat faster than NMR’s over the last 12 months.
| LAZ | NMR | |
|---|---|---|
| RSI ODDS (%) | 7 days ago 69% | 2 days ago 69% |
| Stochastic ODDS (%) | 2 days ago 75% | 2 days ago 55% |
| Momentum ODDS (%) | 2 days ago 74% | 2 days ago 70% |
| MACD ODDS (%) | N/A | 2 days ago 73% |
| TrendWeek ODDS (%) | 2 days ago 75% | 2 days ago 66% |
| TrendMonth ODDS (%) | 2 days ago 73% | 2 days ago 56% |
| Advances ODDS (%) | 2 days ago 71% | 14 days ago 68% |
| Declines ODDS (%) | 6 days ago 72% | 6 days ago 55% |
| BollingerBands ODDS (%) | 2 days ago 71% | 2 days ago 56% |
| Aroon ODDS (%) | 2 days ago 72% | 2 days ago 61% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
LAZ’s FA Score shows that 0 FA rating(s) are green while NMR’s FA Score has 2 green FA rating(s).
- LAZ’s FA Score: 0 green, 5 red.
- NMR’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
LAZ’s TA Score shows that 5 TA indicator(s) are bullish while NMR’s TA Score has 4 bullish TA indicator(s).
- LAZ’s TA Score: 5 bullish, 4 bearish.
- NMR’s TA Score: 4 bullish, 4 bearish.
Price Growth
LAZ (@Investment Banks/Brokers) experienced а +7.10% price change this week, while NMR (@Investment Banks/Brokers) price change was +0.42% for the same time period.
The average weekly price growth across all stocks in the @Investment Banks/Brokers industry was -3.40%. For the same industry, the average monthly price growth was -18.39%, and the average quarterly price growth was -23.03%.
Reported Earning Dates
LAZ is expected to report earnings on Feb 04, 2027.
NMR is expected to report earnings on Feb 03, 2027.
Industries' Descriptions
@Investment Banks/Brokers (-3.40% weekly)These banks specialize in underwriting (helping companies with debt financing or equity issuances), IPOs, facilitating mergers and other corporate reorganizations and acting as a broker or financial advisor for institutions. They might also trade securities on their own accounts. Investment banks potentially thrive on expanding its network of clients, since that could help them increase profits. Goldman Sachs, Morgan Stanley and CME Group Inc are some of the largest investment banking companies.
Advertisement
LAZ and
Correlation & Price change
A.I.dvisor indicates that over the last year, LAZ has been closely correlated with MC. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if LAZ jumps, then MC could also see price increases.
NMR and
Correlation & Price change
A.I.dvisor indicates that over the last year, NMR has been loosely correlated with MS. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if NMR jumps, then MS could also see price increases.